The increased expression of upstream complement components C1q, C3, and C4 in the peripheral blood and spinal cerebral fluid (SCF) in living ALS patients and in the postmortem motor cortex and spinal cord in proximity to motor neurons found in ALS individuals suggests an ongoing complement activation process [134,135,136,137]. The gene discussed is C3; the disease is amyotrophic lateral sclerosis.